Selinexor for CLL - mechanism of action and combination with ibrutinib
Overview of CLL12 trial of ibrutinib aiming to delay chemoimmunotherapy
CLL highlights from ASCO 2016: HELIOS trial, CAR T-cell therapy and CLL-IPI
How far are we from a cure for CLL?
Overview of a Phase Ib study of venetoclax and obinutuzumab in CLL